-
Something wrong with this record ?
The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage
Pachl J, Haninec P, Tencer T, Mizner P, Houst'ava L, Tomás R, Waldauf P.
Language English Country Austria
Document type Clinical Trial
- MeSH
- Adult MeSH
- Injections, Intraventricular MeSH
- Vasospasm, Intracranial diagnosis etiology prevention & control MeSH
- Catheterization methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Nitroprusside administration & dosage MeSH
- Aged MeSH
- Subarachnoid Hemorrhage diagnosis drug therapy complications MeSH
- Subarachnoid Space drug effects MeSH
- Vasodilator Agents administration & dosage MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Clinical Trial MeSH
OBJECTIVE: The aim of this study was to evaluate the effect of preventive and therapeutic use of subarachnoid sodium nitroprusside (SNP) administration in patients with non-traumatic subarachnoid haemorrhage (SAH). METHODS: All consecutive adult patients admitted in the period 2000-2003 with SAH, Hunt-Hess grade I-IV, indicated for neurosurgical intervention, were enrolled in the study. In the postoperative period they were treated with mechanical ventilation and triple H protocol with nimodipine. Subarachnoid preventive SNP was administred in initial dose of 1 mg by catheter inserted into basal cisterns during the neurosurgical procedure. The timing of following dosage was directed by the changes of respiratory parameters of brain tissue in the region of interest by multiparameter sensor (Codman Neurotrend) and findings of blood flow velocity on the level of circle of Willis were measured by transcranial doppler ultrasonography (TCD). RESULTS: 17 patients were enrolled to study. All patients survived. No brain infarction developed. The increase blood flow velocity was found in three patients. CONCLUSION: Preventive subarachnoid use of SNP in combination with multimodal monitoring might be a possible preventive strategy. Its efficacy has to be proved on a greater group of patients in the future. The therapeutical use of SNP requires an increase in application rate.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520375
- 003
- CZ-PrNML
- 005
- 20111210131111.0
- 008
- 090331s2005 au e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Pachl, Jan, $d 1949- $7 nlk19990073644
- 245 14
- $a The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage / $c Pachl J, Haninec P, Tencer T, Mizner P, Houst'ava L, Tomás R, Waldauf P.
- 314 __
- $a Department of Anaesthesiology and CCM, University Hospital Kralovske Vinohrady, 3rd School of Medicine, Charles's University, Prague, Czech Republic. pachl@fnkv.cz
- 520 9_
- $a OBJECTIVE: The aim of this study was to evaluate the effect of preventive and therapeutic use of subarachnoid sodium nitroprusside (SNP) administration in patients with non-traumatic subarachnoid haemorrhage (SAH). METHODS: All consecutive adult patients admitted in the period 2000-2003 with SAH, Hunt-Hess grade I-IV, indicated for neurosurgical intervention, were enrolled in the study. In the postoperative period they were treated with mechanical ventilation and triple H protocol with nimodipine. Subarachnoid preventive SNP was administred in initial dose of 1 mg by catheter inserted into basal cisterns during the neurosurgical procedure. The timing of following dosage was directed by the changes of respiratory parameters of brain tissue in the region of interest by multiparameter sensor (Codman Neurotrend) and findings of blood flow velocity on the level of circle of Willis were measured by transcranial doppler ultrasonography (TCD). RESULTS: 17 patients were enrolled to study. All patients survived. No brain infarction developed. The increase blood flow velocity was found in three patients. CONCLUSION: Preventive subarachnoid use of SNP in combination with multimodal monitoring might be a possible preventive strategy. Its efficacy has to be proved on a greater group of patients in the future. The therapeutical use of SNP requires an increase in application rate.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a katetrizace $x metody $7 D002404
- 650 _2
- $a injekce intraventrikulární $7 D007276
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nitroprusid $x aplikace a dávkování $7 D009599
- 650 _2
- $a subarachnoidální krvácení $x diagnóza $x farmakoterapie $x komplikace $7 D013345
- 650 _2
- $a subarachnoidální prostor $x účinky léků $7 D013346
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a vazodilatancia $x aplikace a dávkování $7 D014665
- 650 _2
- $a intrakraniální vazospazmus $x diagnóza $x etiologie $x prevence a kontrola $7 D020301
- 655 _2
- $a klinické zkoušky $7 D016430
- 700 1_
- $a Haninec, Pavel, $d 1958- $7 xx0063333
- 700 1_
- $a Tencer, Tomáš $7 xx0128841
- 700 1_
- $a Mizner, Petr $7 xx0128781
- 700 1_
- $a Houšťava, Ladislav, $7 xx0076896 $d -2014
- 700 1_
- $a Tomáš, Robert $7 xx0056248
- 700 1_
- $a Waldauf, Petr $7 xx0085547
- 773 0_
- $w MED00011359 $t Acta neurochirurgica. Supplementum $g Roč. 95 (2005), s. 141-145 $x 0065-1419
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090325104238 $b ABA008
- 991 __
- $a 20090713160648 $b ABA008
- 999 __
- $a ok $b bmc $g 638178 $s 490977
- BAS __
- $a 3
- BMC __
- $a 2005 $b 95 $d 141-145 $i 0065-1419 $m Acta neurochirurgica. Supplementum $x MED00011359
- LZP __
- $a 2009-B1/dkme